Chennai Meenakshi Multispeciality Hospital Ltd (523489)

Chennai Meenakshi Multispeciality Hospital has released newspaper clippings confirming the publication of its unaudited financial results for the quarter and half-year ended September 30, 2026. The results were approved by the Board of Directors on November 2, 2026, and published in the Financial Express and Makkal Kural on November 3, 2026. This filing is a routine procedural requirement under Regulation 47 of SEBI LODR without new financial disclosures provided in the excerpt. The micro-cap company currently operates with a market capitalization of Rs 28 Cr and a negative net worth of Rs -3 Cr.

• Board approved unaudited financial results on November 2, 2026
• Results published in Financial Express (English) and Makkal Kural (Tamil) on November 3, 2026
• Filing satisfies compliance under Regulation 47 of SEBI (LODR) Regulations 2015

Chennai Meenakshi Multispeciality Hospital reported a marginal net profit of ₹0.28 lakh for Q1 FY27 (quarter ended June 30, 2026), recovering from a net loss of ₹74.11 lakh in the year-ago period. Revenue from operations declined 1.7% YoY to ₹850.02 lakh compared to ₹864.90 lakh in Q1 FY26, and dropped 13.4% sequentially from ₹981.05 lakh in Q4 FY26. Along with earnings, the company appointed Dr. Thanigai Vendan Moorthy as CEO for a 5-year term and inducted three new Independent Directors. Total expenses decreased to ₹871.98 lakh from ₹967.47 lakh YoY, aided by a reduction in employee benefit costs.

• Revenue from operations stood at ₹850.02 lakh vs ₹864.90 lakh in Q1 FY26 and ₹981.05 lakh in Q4 FY26
• Net profit after tax turned positive at ₹0.28 lakh compared to a net loss of ₹74.11 lakh in Q1 FY26
• Total expenses reduced to ₹871.98 lakh from ₹967.47 lakh in Q1 FY26
• Appointment of Dr. Thanigai Vendan Moorthy as CEO and KMP for 5 years effective August 11, 2026
• Appointment of three Additional Independent Directors and reconstitution of Audit and Stakeholders committees

Chennai Meenakshi Multispeciality Hospital Ltd announced that shareholders approved key appointments during its 36th Annual General Meeting on September 30, 2026. Mr. R V Ramanuja Bharathi has been appointed as a Non-Executive Independent Director for a 5-year tenure effective August 11, 2026. Additionally, Mr. T. Murugan was appointed as the Secretarial Auditor for FY 2026-27. These governance updates arrive as the micro-cap hospital operator (market cap ₹28 Cr) navigates negative net worth (-₹3 Cr) and an operating margin of 1.5%.

• Shareholders approved the appointment of Mr. R V Ramanuja Bharathi as Independent Director at the 36th AGM on September 30, 2026
• Independent Director appointment is for a term of 5 consecutive years effective from August 11, 2026
• Mr. T. Murugan appointed as Secretarial Auditor for FY 2026-27
• Company trades at a market cap of ₹28 Cr against TTM revenue of ₹37 Cr

Chennai Meenakshi Multispeciality Hospital Limited conducted its 36th Annual General Meeting on September 30, 2026, with 42 members attending via video conferencing. Key resolutions tabled included the adoption of FY26 financial statements and the reappointment of Mrs. R. Gomathi as Chairman and Managing Director for a 3-year term starting November 11, 2026, at a monthly remuneration of ₹1,00,000. Additionally, multiple director appointments and the appointment of the secretarial auditor for ₹60,000 remuneration were put to vote. Voting results will be disclosed within 48 hours.

• 36th AGM held on September 30, 2026, attended by 42 members via video conferencing
• Special resolution to reappoint Mrs. R. Gomathi as CMD for 3 years from November 11, 2026, at ₹1,00,000 monthly remuneration
• Proposed appointment of Mr. T. Murugan as Secretarial Auditor for FY 2026-27 at a fee of ₹60,000
• Two Independent Directors (Mr. M. Karunakaran and Mr. R.V. Ramanuja Bharathi) appointed for 5-year terms ending August 2031

Chennai Meenakshi Multispeciality Hospital has postponed its Board of Directors meeting from August 28, 2026, to September 1, 2026, citing administrative reasons. The board is scheduled to consider and approve items relating to the 36th Annual General Meeting (AGM) for the fiscal year ended March 31, 2026. Agenda items include finalizing the AGM date, approving the Board's Report, and setting book closure and e-voting record dates.

• Board meeting rescheduled from August 28, 2026, to September 1, 2026
• Postponement attributed to unavoidable administrative reasons
• Agenda covers approving notice and date for the 36th Annual General Meeting
• Board to determine book closure and cut-off dates for e-voting for FY ended March 31, 2026

Chennai Meenakshi Multispeciality Hospital Ltd has scheduled a meeting of its Board of Directors on August 28, 2026. The Board will consider and fix the date, time, and mode/venue for the company's 36th Annual General Meeting (AGM) for the financial year ended March 31, 2026. Key administrative agenda items also include approving the Board's Report, setting book closure and e-voting record dates, and appointing a scrutinizer.

• Board of Directors meeting scheduled for August 28, 2026
• To determine the date, time, and venue/mode for the 36th AGM
• Approval of Board's Report and annexures for FY ended March 31, 2026
• Determination of book closure dates and cut-off date for e-voting

Chennai Meenakshi Multispeciality Hospital (CMMH) reported a marginal net profit of ₹0.28 lakhs for Q1 FY27, recovering from a loss of ₹74.41 lakhs in the year-ago period. Revenue from operations declined 1.7% YoY to ₹8.50 crore. The board significantly overhauled its leadership by appointing Dr. Thanigai Vendan Moorthy as CEO for a 5-year term and adding three new Independent Directors. Despite the break-even quarter, the company remains in a precarious financial position with a negative net worth of ₹3 crore and debt of ₹11 crore.

• Reported a marginal net profit of ₹0.28 lakhs in Q1 FY27 compared to a loss of ₹74.41 lakhs in Q1 FY26.
• Revenue from operations stood at ₹8.50 crore, a sequential decline of 13.4% from ₹9.81 crore in March 2026.
• Appointed Dr. Thanigai Vendan Moorthy as CEO and Key Managerial Personnel for a 5-year term effective August 11, 2026.
• Appointed three new Independent Directors (Mr. A F Simeon Telfer, Mr. R V Ramanuja Bharathi, and Ms. Sindu Chawla) for 5-year terms.
• Total Comprehensive Loss for the quarter stood at ₹1.49 lakhs after accounting for remeasurements.

Chennai Meenakshi Multispeciality Hospital (CMMH) reported a marginal net profit of Rs 0.28 lakhs for Q1 FY27, a recovery from a loss of Rs 74.11 lakhs in the same quarter last year. Revenue from operations stood at Rs 8.50 Cr, down 13.3% from Rs 9.81 Cr in the preceding March quarter. The company significantly restructured its leadership, appointing Dr. Thanigai Vendan Moorrthy as CEO and three new Independent Directors for 5-year terms. This management refresh is critical as the company currently operates with a negative net worth of Rs 3 Cr and debt of Rs 11 Cr.

• Reported a marginal Net Profit of Rs 0.28 lakhs in Q1 FY27, compared to a loss of Rs 74.11 lakhs in Q1 FY26.
• Revenue from operations declined to Rs 8.50 Cr from Rs 9.81 Cr in the previous quarter (Mar 2026).
• Appointed Dr. Thanigai Vendan Moorrthy as CEO for a 5-year term effective August 11, 2026.
• Three new Independent Directors appointed to the board, leading to a full reconstitution of the Audit and Stakeholders Relationship Committees.
• Total Comprehensive Income for the quarter was a loss of Rs 1.49 lakhs due to remeasurement of defined benefit liabilities.

Chennai Meenakshi Multispeciality Hospital has appointed Mr. M. Karunakaran as an Additional Independent Director for a five-year term starting August 7, 2026. Mr. Karunakaran, a retired Chief Manager from Indian Overseas Bank and a practicing advocate, will also chair the Audit and Stakeholder’s Relationship Committees. This governance update comes as the micro-cap company (Rs 29 Cr market cap) struggles with a negative net worth of Rs -3 Cr and a TTM loss of Rs 1 Cr. The appointment is intended to bring banking and legal expertise to the board's oversight functions.

• Appointment of Mr. M. Karunakaran as Independent Director for a 5-year term effective August 7, 2026
• Mr. Karunakaran appointed as Chairman of the Audit Committee and Stakeholder’s Relationship Committee
• Appointee brings experience as a retired Chief Manager of Indian Overseas Bank and a practicing Advocate
• Company reports a negative net worth of Rs -3 Cr against a debt of Rs 11 Cr
• TTM revenue stands at Rs 37 Cr with an operating profit margin of -0.8%

Chennai Meenakshi Multispeciality Hospital has scheduled a board meeting for August 11, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is currently in a fragile financial position with a negative net worth of Rs -3 Cr and a TTM net loss of Rs -1 Cr. While TTM revenue stands at Rs 37 Cr, the operating margin remains slightly negative at -0.8%. Investors will be looking for signs of operational recovery to address the negative equity base.

• Board meeting scheduled for August 11, 2026, at 11:30 A.M. in Chennai
• Review of unaudited financial results for the quarter ended June 30, 2026
• Trading window remains closed from July 1, 2026, until 48 hours post-announcement
• Company reported a marginal net loss of Rs 0.02 Cr in the preceding March 2026 quarter
• TTM revenue of Rs 37 Cr is approximately 1.27x the current market capitalization of Rs 29 Cr

Chennai Meenakshi Multispeciality Hospital has scheduled a board meeting on August 7, 2026, to consider the appointment of M. Karunakaran as an Additional (Independent) Director. The meeting is being held at short notice via virtual mode, following the required consent from existing independent directors. This administrative move comes as the company manages a small market cap of Rs 29 Cr and a negative net worth of Rs 3 Cr. Investors should note the company's TTM revenue stands at Rs 37 Cr with a net loss of Rs 1 Cr.

• Board meeting scheduled for August 7, 2026, at 12:30 PM IST via video conference.
• Proposal to appoint M. Karunakaran (DIN: 11874200) as an Additional (Independent) Director.
• Meeting convened at short notice under Section 173(3) of the Companies Act, 2013.
• Company currently operates with a negative net worth of Rs 3 Cr as of the latest financial data.
• TTM revenue is Rs 37 Cr against a debt of Rs 11 Cr.

Chennai Meenakshi Multispeciality Hospital Ltd has announced the reconstitution of its Nomination & Remuneration Committee (NRC) via a circular resolution passed on August 4, 2026. The committee now consists of three members, with Mrs. Shama Dhilip appointed as Chairman. This is a procedural governance update for the micro-cap company, which currently operates with a negative net worth of ₹3 Cr and TTM revenue of ₹37 Cr. The change ensures continued compliance with SEBI Listing Obligations and Disclosure Requirements (LODR).

• Board approved the NRC reconstitution via circular resolution on August 4, 2026
• The committee now consists of 3 members: Mrs. Shama Dhilip (Chairman), Mr. Edward M Prabhakar, and Mr. Akash Prabhakar
• Company reported a TTM revenue of ₹37.04 Cr for FY26 against a market cap of ₹27 Cr
• The hospital remains in a financially stressed position with a negative net worth of ₹3 Cr

Chennai Meenakshi Multispeciality Hospital has published newspaper advertisements regarding a special window for the transfer and dematerialization of physical securities. This action follows a SEBI circular dated January 30, 2026, aimed at streamlining the conversion of physical shares into electronic form. The advertisements were released in Financial Express and Makkal Kural on July 21, 2026. This is a procedural regulatory compliance matter with no impact on the company's financial performance or hospital operations.

• Newspaper advertisements published on July 21, 2026, in Financial Express and Makkal Kural
• Action taken in accordance with SEBI Circular dated January 30, 2026
• Focuses on the transfer and dematerialization of physical equity shares
• Company currently operates with a small market capitalization of Rs 27 Cr
• Financial context shows a negative net worth of Rs -3 Cr as of the latest reporting